SCHEMBL4564350

SCHEMBL4564350

COc1ccc(C(S)C(C)CO)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCB11 O95342 1/20 0.49
TSHR P16473 2/20 0.43
CYP2C9 P11712 1/20 0.43
GPR88 Q9GZN0 1/20 0.42
AOC3 Q16853 2/20 0.42
HDAC3 O15379 1/20 0.42
HDAC4 P56524 1/20 0.42
HDAC1 Q13547 1/20 0.42
HDAC7 Q8WUI4 1/20 0.42
HDAC2 Q92769 1/20 0.42
HDAC10 Q969S8 1/20 0.42
HDAC11 Q96DB2 1/20 0.42
HDAC8 Q9BY41 1/20 0.42
HDAC6 Q9UBN7 1/20 0.42
HDAC9 Q9UKV0 1/20 0.42
HDAC5 Q9UQL6 1/20 0.42
L3MBTL1 Q9Y468 2/20 0.41
NR1I2 O75469 1/20 0.41
ALDH1A1 P00352 2/20 0.41
RAB9A P51151 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22640257 0.81 ABCB11 (0.51) ABCB11TSHRCYP2C9GPR88AOC3
SCHEMBL338074 0.78 CA1 (0.55) TSHRAOC3L3MBTL1ALDH1A1RAB9A
SCHEMBL6704463 0.78 CA1 (0.55) TSHRAOC3L3MBTL1ALDH1A1RAB9A
SCHEMBL7419755 0.76 ABCB11 (0.70) ABCB11TSHRCYP2C9GPR88AOC3
SCHEMBL7051522 0.76 ABCB11 (0.70) ABCB11TSHRCYP2C9GPR88AOC3
SCHEMBL9711999 0.74 ABCB11 (0.52) ABCB11TSHRCYP2C9GPR88AOC3
SCHEMBL7128925 0.74 ABCB11 (0.52) ABCB11TSHRCYP2C9GPR88AOC3
SCHEMBL1959718 0.73 CA1 (0.55) TSHRAOC3L3MBTL1ALDH1A1RAB9A
SCHEMBL4434527 0.73 POLB (0.45) TSHRL3MBTL1CA12CA1CA2
SCHEMBL17660055 0.72 AOC3 (0.61) ABCB11TSHRCYP2C9AOC3L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2089374-A2 METHOD FOR THE SYNTHESIS OF N- [3- [ (2-METHOXYPHÉNYL) SULFANY] -2- METHYLPROPY]-3,4-DIHYDRO-2H-1,5-BENZOXATHIEPIN-3-AMINE.<0} Pierre Fabre Medicament (FR) 2009-08-19 EP disclosed
WO-2008068403-A2 METHOD FOR THE SYNTHESIS OF N- [3- [ (2-METHOXYPHÉNYL) SULFANYL] -2- METHYLPROPYL] -3,4-DIHYDRO-2H-1,5-BENZOXATHIEPIN-3-AMINE<0} PIERRE FABRE MEDICAMENT (FR) 2008-06-12 WO disclosed